Andrew J. Greenfield
Net Worth

Last updated:

What is Andrew J. Greenfield net worth?

The estimated net worth of Mr. Andrew J. Greenfield is at least $51,260,774 as of 28 Jan 2021. He owns shares worth $12,165,969 as insider, has earned $28,967,365 from insider trading and has received compensation worth at least $10,127,440 in Abiomed, Inc. and Abiomed, Inc..

What is the salary of Andrew J. Greenfield?

Mr. Andrew J. Greenfield salary is $638,670 per year as Vice President & Chief Commercial Officer in Abiomed, Inc.. He also receives $547,390 as Vice President & Chief Commercial Officer in Abiomed, Inc..

How old is Andrew J. Greenfield?

Mr. Andrew J. Greenfield is 52 years old, born in 1973.

What stocks does Andrew J. Greenfield currently own?

As insider, Mr. Andrew J. Greenfield owns shares in one company:

Company Title Shares Price per share Total value
Abiomed, Inc. (ABMD) Vice President & Chief Commercial Officer 31,930 $381.02 $12,165,969

What does Abiomed, Inc. do?

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

ABMD logo
ABMD
Abiomed, Inc.
$381.02

Andrew J. Greenfield insider trading

Abiomed, Inc.

Mr. Andrew J. Greenfield has made 43 insider trades between 2010-2021, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of ABMD stock worth $331,250 on 28 Jan 2021.

The largest trade he's ever made was exercising 40,000 units of ABMD stock on 8 Nov 2013. As of 28 Jan 2021 he still owns at least 31,930 units of ABMD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $.01 par value 5,000 $66.25 $331,250
Option
Stock Option (right to buy) 5,000 $66.25 $331,250
Option
Common Stock, $.01 par value 5,000 $66.25 $331,250
Sale
Common Stock, $.01 par value 10,000 $171.28 $1,712,750
Option
Common Stock, $.01 par value 5,000 $21.55 $107,750
Option
Stock Option (right to buy) 5,000 $21.55 $107,750
Sale
Common Stock, $.01 par value 1,682 $297.13 $499,773
Sale
Common Stock, $.01 par value 1,682 $297.13 $499,773
Sale
Common Stock, $.01 par value 5,474 $295.91 $1,619,811
Sale
Common Stock, $.01 par value 5,474 $295.91 $1,619,811
Option
Stock Option (right to buy) 5,000 $21.55 $107,750
Sale
Common Stock, $.01 par value 5,000 $21.55 $107,750
Option
Common Stock, $.01 par value 5,000 $21.55 $107,750
Sale
Common Stock, $.01 par value 4,440 $395 $1,753,800
Option
Common Stock, $.01 par value 20,000 $17.31 $346,200
Option
Stock Option (right to buy) 10,000 $14.39 $143,900
Option
Common Stock, $.01 par value 20,000 $17.31 $346,200
Sale
Common Stock, $.01 par value 20,000 $270.82 $5,416,300
Option
Stock Option (right to buy) 10,000 $14.39 $143,900
Sale
Common Stock, $.01 par value 11,282 $169.57 $1,913,066
Option
Common Stock, $.01 par value 10,000 $14.39 $143,900
Option
Stock Option (Right to Buy) 10,000 $14.39 $143,900
Sale
Common Stock, $.01 par value 10,000 $14.39 $143,900
Sale
Common Stock, $.01 par value 10,000 $119.03 $1,190,250
Option
Stock Option (right to buy) 10,000 $22.44 $224,400
Option
Common Stock, $.01 par value 10,000 $22.44 $224,400
Option
Common Stock, $.01 par value 10,000 $22.44 $224,400
Option
Stock Option (right to buy) 10,000 $22.44 $224,400
Sale
Common Stock, $.01 par value 10,000 $22.44 $224,400
Option
Stock Option (right to buy) 9,000 $13.8 $124,200
Option
Common Stock, $.01 par value 9,000 $13.8 $124,200
Sale
Common Stock, $.01 par value 9,000 $13.8 $124,200
Option
Common Stock, $.01 par value 10,000 $11.27 $112,700
Sale
Common Stock, $.01 par value 10,000 $11.27 $112,700
Option
Stock Option (right to buy) 10,000 $11.27 $112,700
Option
Common Stock, $.01 par value 7,245 $94.15 $682,102
Sale
Common Stock, $.01 par value 7,245 $94.15 $682,102
Sale
Common Stock, $.01 par value 7,755 $94.07 $729,474
Option
Stock Option (right to buy) 15,000 $11.27 $169,050
Option
Common Stock, $.01 par value 7,755 $94.07 $729,474
Option
Common Stock, $.01 par value 5,228 $89 $465,292
Sale
Common Stock, $.01 par value 5,228 $89 $465,292
Option
Common Stock, $.01 par value 19,572 $89.07 $1,743,356
Sale
Common Stock, $.01 par value 19,572 $89.07 $1,743,356
Option
Stock Option (right to buy) 24,800 $11.27 $279,496
Option
Common Stock, $.01 par value 200 $11.27 $2,254
Option
Stock Option (right to buy) 200 $11.27 $2,254
Sale
Common Stock, $.01 par value 200 $11.27 $2,254
Sale
Common Stock, $.01 par value 3,185 $65 $207,025
Sale
Common Stock, $.01 par value 3,357 $60.93 $204,529
Sale
Common Stock, $.01 par value 10,654 $67.42 $718,250
Option
Stock Option (right to buy) 22,881 $13.57 $310,495
Option
Common Stock, $.01 par value 22,881 $13.57 $310,495
Sale
Common Stock, $.01 par value 22,881 $67.1 $1,535,224
Option
Common Stock, $.01 par value 17,119 $13.57 $232,305
Option
Stock Option (right to buy) 17,119 $13.57 $232,305
Sale
Common Stock, $.01 par value 20,508 $71.54 $1,467,142
Option
Stock Option (right to buy) 15,000 $8.77 $131,550
Sale
Common Stock, $.01 par value 15,000 $8.77 $131,550
Option
Common Stock, $.01 par value 15,000 $8.77 $131,550
Sale
Common Stock, $.01 par 9,148 $25 $228,700
Sale
Common Stock, $.01 par value 3,943 $21.21 $83,619
Sale
Common Stock, $.01 par 3,083 $20.96 $64,629
Sale
Common Stock, $.01 par 952 $20.94 $19,939
Sale
Common Stock, $.01 par 40,000 $26.65 $1,066,040
Option
Stock Option (right to buy) 10,000 $8.77 $87,700
Option
Common Stock, $.01 par 40,000 $7.32 $292,600
Sale
Common Stock, $.01 par 25,835 $25 $645,875
Option
Common Stock, $.01 par 25,835 $12.17 $314,412
Purchase
Stock Option (right to buy) 5,835 $14.98 $87,408
Option
Common Stock, $.01 par 24,165 $14.98 $361,992
Purchase
Stock Option (right to buy) 24,165 $14.98 $361,992
Sale
Common Stock, $.01 par 24,165 $14.98 $361,992
Sale
Common Stock, $.01 par 8,334 $21.42 $178,548
Sale
Common Stock, $.01 par 8,583 $22.17 $190,302
Sale
Common Stock, $.01 par 1,666 $21.63 $36,036
Sale
Common Stock, $.01 par 7,673 $19.7 $151,120
Option
Stock Option (right to buy) 20,000 $14.98 $299,600
Sale
Common Stock, $.01 par value 20,000 $14.98 $299,600
Option
Common Stock, $.01 par value 20,000 $14.98 $299,600
Option
Common Stock, $.01 par value 20,000 $14.98 $299,600
Option
Stock Option (right to buy) 20,000 $14.98 $299,600
Sale
Common Stock, $.01 par value 20,000 $14.98 $299,600
Sale
Common Stock, $.01 par value 4,428 $17 $75,276
Sale
Common Stock, $.01 par value 3,905 $16.02 $62,546
Sale
Common Stock, $.01 par value 3,891 $9.5 $36,965
Sale
Common Stock, $.01 par value 1,192 $9.1 $10,847

Abiomed key executives

Abiomed, Inc. executives and other stock owners filed with the SEC: